Emergence of NDM-1 in Association with OXA-48 in Klebsiella pneumoniae from Tunisia
Author(s) -
Adam Ben Nasr,
Dominique Decré,
Fabrice Compain,
Nathalie Genel,
Farouk Barguellil,
Guillaume Arlet
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00536-13
Subject(s) - klebsiella pneumoniae , microbiology and biotechnology , klebsiella infections , enterobacteriaceae , biology , association (psychology) , klebsiella , beta lactam , medicine , antibiotics , genetics , escherichia coli , gene , psychology , psychotherapist
The carbapenemase New Delhi metallo-β-lactamase-1 (NDM-1), initially identified in Escherichia coli and Klebsiella pneumoniae in 2008 in a Swedish patient who was repatriated to Sweden from India ([1][1]), is spreading rapidly worldwide except in Central and South America. Most of the reported
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom